Hans-Holger Bleß
ORCID: 0000-0001-7643-9966
has been a partner at _fbeta since April 2021 and heads the Healthcare Research & Market Access division and the Digital Health division. After working in public pharmacies, he worked for AOK Brandenburg, where he most recently headed the “Principles and Contracts for Medicines” department. From 2009 to 2018 he worked at the IGES Institute, where he headed the health services research department from 2011 to 2016 and the HTA & Value Strategy department from 2017 to 2018. From 2019 to 2021 he was managing director of the Institute for Applied Health Services Research (inav). He studied pharmacy at the Free University of Berlin.
Articles
- Multimodal pain therapy in patients with endometriosis: Care structure in German pain centers
MVF 04/24
- Diagnosis of metabolic dysfunction-associated steatohepatitis (MASH)
- Diagnosis of metabolic dysfunction-associated steatohepatitis (MASH) - Review, Part 1
MVF 02/24
- Zwischen Konsistenz und Flexibilität
MVF 06/23
- Evidence requirements for biosimilar substitution
Issue 02/2020
- “It’s about ideas and useful basic principles”
Issue 04/2019
- Application-accompanying data in the benefit assessment
Issue 01/2020
- Status, deficits and challenges in the care of peripheral arterial disease
Issue 03/2015
- Deficits and approaches in stroke prevention in atrial fibrillation
Issue 01/2016
- “Between value decisions and balancing”
Issue 05/2014
- Care situation for patients with chronic coronary heart disease (CHD)
Issue 06/2014
